Nanoinformatics knowledge infrastructures: Bringing efficient information management to nanomedical research

Computational Science and Discovery

Volumn 6, Issue 1, 2013, Pages

  De La Iglesia, D ^a   Cachau, R E ^b   Garcia Remesal M ^a   Maojo, V ^a  

^a UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL DEVICES; CHARACTERIZATION OF NANOPARTICLES; COMPUTATIONAL APPROACH; DRUG DELIVERY SYSTEM; MODEL AND SIMULATION; NANOTECHNOLOGY RESEARCH; SCIENTIFIC DISCIPLINE; SPECIAL PROPERTIES;

COMPUTATIONAL METHODS; COMPUTER SIMULATION; DATA HANDLING; DIGITAL STORAGE; DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOTECHNOLOGY; RESEARCH;

INFORMATION MANAGEMENT;

EID: 84891553402     PISSN: 17494680     EISSN: 17494699     Source Type: Journal    
DOI: 10.1088/1749-4699/6/1/014011     Document Type: Article

References (97)

1. Bailey R C, Kwong G A, Radu C G, Witte O N and Heath J R 2007 DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins J. Am. Chem. Soc. 129 1959-67
2. Bairoch A and Apweiler R 2000 The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000 Nucleic Acids Res. 28 45-8 (Pubitemid 30047711)
3. Bairoch A et al 2005 The Universal Protein Resource (UniProt) Nucleic Acids Res. 33 D154-9 (Pubitemid 40207850)
4. Baker N A, Fritts M, Guccione S, Paik D S, Pappu R V, Patri A, Rubin D, Shaw S Y and Thomas D G 2009 Nanotechnology Informatics White Paper caBIG National Cancer Institute February 2009 (non-peer reviewed manuscript)
5. Bellare J R 2011 Nanotechnology and nanomedicine for healthcare: challenges in translating innovations from bench to bedside J. Biomed. Nanotechnol. 7 36-7
6. Benson D A, Karsch-Mizrachi I, Clark K, Lipman D J, Ostell J and Sayers E W 2012 GenBank Nucleic Acids Res. 40 D48-53
7. Berman H M, Henrick K and Nakamura H 2003 Announcing the worldwide protein data bank Nature Struct. Biol. 10 980 (Pubitemid 37500485)
8. Berman H M, Westbrook J, Feng Z, Gilliland G, Bhat T N, Weissig H, Shindyalov I N and Bourne P E 2000 The protein data bank Nucleic Acids Res. 28 235-42 (Pubitemid 30047768)
9. Bikiaris D, Koutris E and Karavas E 2007 New aspects in sustained drug release formulations Recent Pat. Drug Deliv Formul. 1 201-13
10. Braun T, Schubert A and Zsindely S 1997 Nanoscience and nanotechnology on the balance Scientometrics 38 321-5 (Pubitemid 127457640)
11. Buxton D B 2009 Current status of nanotechnology approaches for cardiovascular disease: a personal perspective Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1 149-55
12. de la Zerda A, Bodapati S, Teed R, May S Y, Tabakman S M, Liu Z, Khuri-Yakub B T, Chen X, Dai H and Gambhir S S 2012 Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice ACS Nano 6 4694-701
13. de la Iglesia D, Chiesa S, Kern J, Maojo V, Martin-Sanchez F, Potamias G, Moustakis V and Mitchell J A 2009 Nanoinformatics: new challenges for biomedical informatics at the nano level Stud. Health Technol. Inform. 150 987-91
14. de la Iglesia D et al 2011 International efforts in nanoinformatics research applied to nanomedicine Methods Inform. Med. 50 84-95
15. de Mel A, Chaloupka K, Malam Y, Darbyshire A, Cousins B and Seifalian A M 2012 A silver nanocomposite biomaterial for blood-contacting implants J. Biomed. Mater. Res. A 100 2348-57
16. Dinov I D et al 2008 iTools: a framework for classification, categorization and integration of computational biology resources PLoS ONE 3 e2265
17. Duncan R and Gaspar R 2011 Nanomedicine(s) under the microscope Mol. Pharm. 8 2101-41
18. Etheridge M L, Campbell S A, Erdman A G, Haynes C L, Wolf S M and McCullough J 2013 The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanomedicine 9 1-14
19. Fathabadi E G, Shelling A N and Al-Kassas R 2012 Nanocarrier systems for delivery of siRNA to ovarian cancer tissues Expert Opin. Drug Deliv. 9 743-54
20. Freitas R A Jr 1999 Nanomedicine, Volume I: Basic Capabilities (Georgetown, TX: Landes Bioscience) Available at: www.nanomedicine.com/NMI/ Glossary.htm
21. Freitas R A Jr 2005 What is nanomedicine? Nanomedicine 1 2-9 (Pubitemid 43963605)
22. García-Remesal M, Cuevas A, Pérez-Rey D, Martín L, Anguita A, de la Iglesia D, de la Calle G, Crespo J and Maojo V 2010 PubDNA finder: a web database linking full-text articles to sequences of nucleic acids Bioinformatics 26 2801-2
23. García-Remesal M, García-Ruiz A, Pérez-Rey D, de la Iglesia D and Maojo V 2013 Using nanoinformatics methods for automatically identifying relevant nanotoxicology entities from the literature Biomed. Res. Int. 2013 410294
24. Ghanbari H, Cousins B G and Seifalian A M 2011 A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS) Macromol. Rapid Commun. 32 1032-46
25. Giam L R, Massich M D, Hao L, Shin Wong L, Mader C C and Mirkin C A 2012 Scanning probe-enabled nanocombinatorics define the relationship between fibronectin feature size and stem cell fate Proc. Natl Acad. Sci. USA 109 4377-82
26. Greenberg A 2009 Integrating nanoscience into the classroom: perspectives on nanoscience education projects ACS Nano 3 762-9
27. Hamosh A, Scott A F, Amberger J S, Bocchini C A and McKusick V A 2005 Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders Nucleic Acids Res. 33 D514-7 (Pubitemid 40207927)
28. Hatto P 2009 International standards for risk management in nanotechnology Nature Nanotechnol. 4 205
29. Haun J B, Yoon T J, Lee H and Weissleder R 2011 Molecular detection of biomarkers and cells using magnetic nanoparticles and diagnostic magnetic resonance Methods Mol. Biol. 726 33-49
30. Huang Z, Chen H, Yip A, Ng G, Guo F, Chen Z K and Roco M C 2003 Longitudinal patent analysis for nanoscale science and engineering: country, institution and technology field J. Nanopart. Res. 5 333-63
31. Huh A J and Kwon Y J 2011 'Nanoantibiotics': a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era J. Control Release 156 128-45
32. Hullman A and Meyer M 2003 Publications and patents in nanotechnology: an overview of previous studies and the state of the art Scientometrics 58 507-27 (Pubitemid 39109239)
33. Jain K K 2011 Nanobiotechnology and personalized medicine Prog. Mol. Biol. Transl. Sci. 104 325-54
34. Jin S, Leach J C and Ye K 2009 Nanoparticle-mediated gene delivery Methods Mol. Biol. 544 547-57
35. Kamphuis M M, Johnston A P, Such G K, Dam H H, Evans R A, Scott A M, Nice E C, Heath J K and Caruso F 2010 Targeting of cancer cells using click-functionalized polymer capsules J. Am. Chem. Soc. 132 15881-3
36. Karalis V and Macheras P 2012 Current regulatory approaches of bioequivalence testing Expert Opin. Drug Metable Toxicol. 8 929-42
37. Kelkar S S and Reineke T M 2011 Theranostics: combining imaging and therapy Bioconjug. Chem. 22 1879-903
38. Kiessling F, Fokong S, Koczera P, Lederle W and Lammers T 2012 Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics J. Nucl. Med. 53 345-8
39. Kircher M F et al 2012 A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle Nature Med. 18 829-34
40. Koria P 2012 Delivery of growth factors for tissue regeneration and wound healing BioDrugs 26 163-75
41. Kumbar S G, Kofron M D, Nair L S and Laurencin C T 2008 Cell Behavior Toward Nanostructured Surfaces Biomedical Nanostructures ed K Gonsalves, C Halberstadt, C T Laurencin and L Nair (New York: Wiley-Interscience) 261-95
42. Lee L L, Chan C K, Ngaim M and Ramakrishna S 2006 Nanotechnology patent landscape 2006 Nano 1 101-13
43. Lemley M A 2005 Patenting nanotechnology Stanford Law Rev. 58 601-30 (Pubitemid 43051838)
44. Li Y, Zheng X, Cao Z, Xu W, Zhang J and Gong M 2012 Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin Int. J. Pharm. 434 209-14
45. Liu R, Zhang H Y, Ji Z X, Rallo R, Xia T, Chang C H, Nel A and Cohen Y 2013 Development of structure-activity relationship for metal oxide nanoparticles Nanoscale 5 5644-53
46. Liu S, Guo Y, Huang R, Li J, Huang S, Kuang Y, Han L and Jiang C 2012 Gene and doxorubicin co-delivery system for targeting therapy of glioma Biomaterials 33 4907-16
47. Lowe H J and Barnett G O 1994 Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches JAMA 271 1103-8 (Pubitemid 24106508)
48. Lynch I, Salvati A and Dawson K A 2009 Protein-nanoparticle interactions: what does the cell see? Nature Nanotechnol. 4 546-7
49. Mailänder V and Landfester K 2009 Interaction of nanoparticles with cells Biomacromolecules 10 2379-400
50. Majzoub E H and Rönnebro E C E 2012 Methodology of materials discovery in complex metal hydrides using experimental and computational tools Mater. Sci. Eng. Rep. 73 15-26
51. Maojo V et al 2010 The ACTION-Grid White Paper: Linking Biomedical Informatics, Grid Computing and Nanomedicine Available at: www.action-grid.eu/ index.php?url=whitepaper (non-peer reviewed manuscript)
52. Maojo V, Crespo J, García-Remesal M, de la Iglesia D, Perez-Rey D and Kulikowski C 2011 Biomedical ontologies: toward scientific debate Methods Inform. Med. 50 203-16
53. Maojo V, Fritts M, de la Iglesia D, Cachau R E, Garcia-Remesal M, Mitchell J A and Kulikowski C 2012a Nanoinformatics: a new area of research in nanomedicine Int. J. Nanomed. 7 3867-90
54. Maojo V et al 2012b Nanoinformatics: developing new computing applications for nanomedicine Comput. Sci. Eng. 94 521-39
55. Martens L, Hermjakob H, Jones P, Adamski M, Taylor C, States D, Gevaert K, Vandekerckhove J and Apweiler R 2005 PRIDE: the proteomics identifications database. Proteomics 5 3537-45 (Pubitemid 41192059)
56. McNeil S E 2011 Characterization of nanoparticles intended for drug delivery (Methods in Molecular Biology vol 697) ed S E McNeil (New York: Humana Press/Springer Science + Business Media) pp 3-8
57. Mentovich E D, Livanov K, Prusty D, Sowwan M and Richter S 2012 DNA-nanoparticle assemblies go organic: macroscopic polymeric materials with nanosized features J. Nanobiotechnol. 10 21
58. Meyer M 2000 Patent citations in a novel field of technology: what can they tell about Interactions of emerging communities of science and technology? Scientometrics 48 151-78
59. Meyer M 2001 Patent citation analysis in a novel field of technology: an exploration of nano-science and nano-technology Scientometrics 51 163-83 (Pubitemid 33690685)
60. Moosavi H, Zeynali M and Pour Z H 2012 Fracture resistance of premolars restored by various types and placement techniques of resin composites Int. J. Dent. 2012 973641
61. Murashov V and Howard J 2008 The US must help set international standards for nanotechnology Nature Nanotechnol. 3 635-6
62. Murashov V and Howard J 2011 Nanotechnology standards Nanostructure Science and Technology ed V Murashov and J Howard (New York: Springer Science + Business Media) pp 1-20
63. Musen M A, Shah N H, Noy N F, Dai B Y, Dorf M, Griffith N, Buntrok J, Jonquet C, Montegut M J and Rubin D L 2008 BioPortal: ontologies and data resources with the click of a mouse AMIA Annu. Symp. Proc. 1223-4
64. National Science and Technology Council 2011 Materials genome initiative for global competitiveness White Paper June 2011 Available at: www.whitehouse.gov/sites/default/files/microsites/ostp/materials-genome- initiative-final. pdf
65. Noy N F et al 2009 BioPortal: ontologies and integrated data resources at the click of a mouse Nucleic Acids Res. 37 W170-3
66. Ostraat M L, Mills K, Murry D and Guzan K 2012 Nanomaterial Registry: an authoritative resource for assessing environmental and biological interactions of nanomaterials TechConnect WORLD: Summit and Innovation Showcase 2012 (Santa Clara, CA, 18-21 June 2012)
67. Parrott M C, Finniss M, Luft J C, Pandya A, Gullapalli A, Napier M E and Desimone J M 2012 Incorporation and Controlled release of silyl ether prodrugs from PRINT nanoparticles J. Am. Chem. Soc. 134 7978-82
68. Pearce T R, Shroff K and Kokkoli E 2012 Peptide targeted lipid nanoparticles for anticancer drug delivery Adv. Mater. 24 3803-22
69. Perán M, García M A, López-Ruiz E, Bustamante M, Jiménez G, Madeddu R and Marchal J A 2012 Functionalized nanostructures with application in regenerative medicine Int. J. Mol. Sci. 13 3847-86
70. Perry J L, Herlihy K P, Napier M E and Desimone J M 2011 PRINT: a novel platform toward shape and size specific nanoparticle theranostics Acc. Chem. Res. 44 990-8
71. Petre C E and Dittmer D P 2007 Liposomal daunorubicin as treatment for Kaposi's sarcoma Int. J. Nanomed. 2 277-88 (Pubitemid 350047773)
72. Ptak K, Farrell D, Panaro N J, Grodzinski P and Barker A D 2010 The NCI alliance for nanotechnology in cancer: achievement and path forward Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2 450-60
73. Puzyn T, Rasulev B, Gajewicz A, Hu X, Dasari T P, Michalkova A, Hwang H M, Toropov A, Leszczynska D and Leszczynski J 2011 Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles Nature Nanotechnol. 6 175-8
74. Qiao W, McLennan M, Kennell R, Ebert D S and Klimeck G 2006 Hub-based simulation and graphics hardware accelerated visualization for nanotechnology applications IEEE Trans. Vis. Comput. Graph. 12 1061-8 (Pubitemid 44955638)
75. Roco M C 2003 Nanotechnology: convergence with modern biology and medicine Curr. Opin. Biotechnol. 14 337-46 (Pubitemid 36782666)
76. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream M A and Barrell B 2000 Artemis: sequence visualization and annotation Bioinformatics 16 944-5
77. Sato K, Yokosuka S, Takigami Y, Hirakuri K, Fujioka K, Manome Y, Sukegawa H, Iwai H and Fukata N 2011 Size-tunable silicon/iron oxide hybrid nanoparticles with fluorescence, superparamagnetism, and biocompatibility J. Am. Chem. Soc. 133 18626-33
78. Scholes G D and Rumbles G 2006 Excitons in nanoscale systems Nature Mater. 5 683-96 (Pubitemid 44320320)
79. Service R F 2005 Materials and biology. Nanotechnology takes aim at cancer Science 310 1132-4 (Pubitemid 41681730)
80. Service R F 2010 Nanotechnology nanoparticle Trojan horses gallop from the lab into the clinic Science 330 314-5
81. Shimoni O, Postma A, Yan Y, Scott A M, Heath J K, Nice E C, Zelikin A N and Caruso F 2012 Macromolecule functionalization of disulfide-bonded polymer hydrogel capsules and cancer cell targeting ACS Nano 6 1463-72
82. Shukla G C, Haque F, Tor Y, Wilhelmsson L M, Toulmé J J, Isambert H, Guo P, Rossi J J, Tenenbaum S A and Shapiro B A 2011 A boost for the emerging field of RNA nanotechnology ACS Nano 5 3405-18
83. Sioutos N, de Coronado S, Haber M W, Hartel F W, Shaiu W L and Wright L W 2007 NCI thesaurus: a semantic model integrating cancer-related clinical and molecular information J. Biomed. Inform. 40 30-43 (Pubitemid 44821015)
84. Tanaka M 2005 Toward a Proposed Ontology for Nanoscience CAIS/ACSI 2005: Data, Information, and Knowledge in a Networked World (London: The University of Western Ontario)
85. Thaxton C S et al 2009 Nanoparticle-based bio-barcode assay redefines 'undetectable' PSA and biochemical recurrence after radical prostatectomy Proc. Natl Acad. Sci. USA 106 18437-42
86. Thomas A R 1997 Bibliographical classification: the ideas and achievements of Henry E Bliss Cataloging Classification Q. 25 51-104 (Pubitemid 128031056)
87. Thomas D G, Pappu R V and Baker N A 2011 NanoParticle ontology for cancer nanotechnology research J. Biomed. Inform. 44 59-74
88. Upadhyay D, Scalia S, Vogel R, Wheate N, Salama R O, Young P M, Traini D and Chrzanowski W 2012 Magnetised thermo responsive lipid vehicles for targeted and controlled lung drug delivery Pharm. Res. 29 2456-67
89. Veetil J V and Ye K 2009 Tailored carbon nanotubes for tissue engineering applications. Biotechnol. Prog. 25 709-21
90. Wang Y, Byrne J D, Napier M E and DeSimone J M 2012 Engineering nanomedicines using stimuli-responsive biomaterials Adv. Drug. Deliv. Rev. 64 1021-30
91. Weidl T, Klein G and Zöllner R 2010 International Handbook on Regulating Nanotechnologies ed G A Hodge, D M Bowman and A D Maynar (Cheltenham: Edward Elgar Publishing) pp 462-83
92. Wishart D S et al 2007 HMDB: the human metabolome database Nucleic Acids Res. 35 D521-6 (Pubitemid 46056263)
93. Wong P K, Ho Y P and Chan C K 2007 Internationalization and evolution of application areas of an emerging technology: the case of nanotechnology Scientometrics 70 715-37
94. Xenarios I, Salwínski L, Duan X J, Higney P, Kim S M and Eisenberg D 2002 DIP, the database of interacting proteins: a research tool for studying cellular networks of protein interactions Nucleic Acids Res. 30 303-5 (Pubitemid 34679570)
95. Xin G, Zhao X, Duan X, Ning Q, Meng M, Meng D and Liu L 2012 Antitumor effect of a generation 4 polyamidoamine dendrimer/cyclooxygenase-2 antisense oligodeoxynucleotide complex on breast cancer in vitro and in vivo Cancer Biother. Radiopharm. 27 77-87
96. Yeri A and Gao D 2011 Biosensing using nanoelectromechanical systems (Biomedical Nanotechnology Methods and Protocols, Methods in Molecular Biology vol 726) ed S J Hurst (Hatfield, Hertfordshire: Humana Press/Springer Science + Business Media) pp 119-40
97. Zuckerman J E, Choi C H, Han H and Davis M E 2012 Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane Proc. Natl Acad. Sci. USA 109 3137-42